Nuvasive Inc
NUVA
Market Cap$2.08B
Close$
$44.54
12% upside
Current Fair Value
12% upsideUndervalued by 12% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.08 Billion |
|---|---|
| Enterprise Value | $2.98 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.78 |
| Beta | 1.07 |
| Outstanding Shares | 52,418,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 56.43 |
|---|---|
| PEG | -6.1 |
| Price to Sales | 1.73 |
| Price to Book Ratio | 2.34 |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | 37.01 |
| Enterprise Value to Net Income | 104 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 1.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Nuvasive Inc
2,800 employees
CEO: J. Christopher Barry NuVasive is a medical devices company based in San Diego, California. The company primarily develops medical devices and procedures for minimally invasive spine surgery. NuVasive's products include software systems for surgical planning ...